tirzepatide gip agonist Effects of tirzepatide, a dual and GLP-1 receptor agonist, on blood pressure, cardiac function, and sympathetic nervous system in stroke-prone spontaneously hypertensive rats 1 and GIP therapy Tirzepatide (GLP-1 / GIP)

The evidence for a class effect or a specific Tirzepatide risk remains uncertain

2 Kidney Damage : Long-term use of semaglutide may increase the risk of kidney problems

Chemotherapy-induced peripheral neuropathy Four randomized controlled trials (RCTs) have evaluated the use of acetyl-L-carnitine (LC) for the prevention of chemotherapy-induced peripheral neuropathy (CIPN)

Ask about pregnancy or breastfeeding, liver or kidney disease, autoimmune conditions, blood-thinning medications, diabetes, active skin infections in the treatment area, recent injectable treatments (past 4 weeks), allergies to bromelain, lecithin, or riboflavin, current medications, keloid scarring history, and thyroid conditions

Chlorpromazine, quinidine, clofazimine, ketoconazole, oral contraceptives, and chemotherapeutic agents (particularly busulfan) may also produce oral pigmentation

10.1016/j.cmet.2017.09.019 13 BellD